RobecoSAM Sustainable Healthy Living Equities D EURRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 30/04/2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | -0,9 | 22,4 | -15,6 | 4,1 | 5,4 | |
+/-Cat | -12,1 | 5,7 | -5,8 | 4,9 | 2,0 | |
+/-Idx | - | -3,7 | -15,7 | 4,3 | -0,9 | |
Categorie: Aandelen Sector Farmacie & Gezondheid | ||||||
Benchmark: Morningstar Gbl Health TME ... |
Kerngegevens | ||
Koers 16/05/2024 | EUR 278,19 | |
Rendement 1 Dag | -0,12% | |
Morningstar Categorie™ | Aandelen Sector Farmacie & Gezondheid | |
ISIN | LU2146189407 | |
Grootte Fonds (Mil) 16/05/2024 | EUR 325,48 | |
Grootte Fondsklasse (Mil) 30/04/2024 | EUR 61,84 | |
Aankoopkosten (Max) | 5,00% | |
Lopende Kosten Factor 02/10/2023 | 1,71% | |
Gesloten voor nieuwe beleggers | nee |
Beleggingsdoelstelling: RobecoSAM Sustainable Healthy Living Equities D EUR |
The Sub-fund has as its sustainable investment objective to promote good health and well-being and contribute to an efficient healthcare system in order to mitigate the rising incidence of lifestyle-driven chronic diseases and increasing healthcare costs, by investing in companies that provide technologies, products or services linked to the prevention of disease via eating healthier diets, exercising regularly and reducing the spread of infectious diseases with hygiene measures. The foregoing is implemented by mainly investing in companies that advance the following United Nations Sustainable Development Goals (UN SDGs): Zero hunger (SDG 2), Good health and wellbeing (SDG 3), and Clean water and sanitation (SDG 6). In addition to pursuing the sustainable investment objective, the Sub-fund at the same time aims to provide long term capital growth. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
David Kägi 29/10/2020 | ||
Dieter Küffer 29/10/2020 | ||
Oprichtingsdatum 29/10/2020 |
Advertentie |
Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI World NR EUR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? RobecoSAM Sustainable Healthy Living Equities D EUR | 31/03/2024 |
|
|
Top 5 posities | Sector | % |
Lonza Group Ltd | Gezondheidszorg | 4,48 |
Boston Scientific Corp | Gezondheidszorg | 4,42 |
Siemens Healthineers AG Register... | Gezondheidszorg | 4,39 |
Bakkafrost P/F | Defensieve Consumptiegoederen | 3,96 |
L'Occitane International SA | Defensieve Consumptiegoederen | 3,45 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
RobecoSAM Sustainable Healthy Living Equities D EUR |